Vanda Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences

WASHINGTON, July 8, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate in two upcoming investor conferences.

On Tuesday, July 9, 2013, the executive team will participate in the Piper Jaffray Catalyst Symposium: Emerging Talent in Biopharma in Boston.

On Wednesday, July 10, 2013, Mihael Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the JMP Securities Healthcare Conference at 12:00 p.m. Eastern Time in New York City.

The JMP conference presentation will be available live on Vanda's corporate website, where it will be archived for 30 days. To access this presentation, go to Vanda's website at www.vandapharma.com and click on the "Presentations" tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.